The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
该发明涵盖了新化合物及其药学可接受的衍生物、药物组合物和治疗由B1布雷金肽受体介导的疾病的方法。
US7414134B2
申请人:——
公开号:US7414134B2
公开(公告)日:2008-08-19
WO2006/44412
申请人:——
公开号:——
公开(公告)日:——
TMSOTf mediated ‘5/6-<i>endo-dig</i>’ reductive hydroamination for the stereoselective synthesis of pyrrolidine and piperidine derivatives
作者:Santosh J. Gharpure、Dharmendra S. Vishwakarma、Raj K. Patel
DOI:10.1039/c9cc03127h
日期:——
A TMSOTf mediated 5/6-endo-dig reductive hydroamination cascade on internal alkynylamines gave expedient, stereoselective access to pyrrolidine and piperidine derivatives. We also demonstrate that a protecting group on nitrogen has a profound effect on the reactivity as well as diastereoselectivity of the reductive hydroamination cascade.